Cited by 22Protein Hydrolysis and Bioactive PeptidesSeaweed-derived Bioactive CompoundsBlood Pressure and Hypertension Studies

Antihypertensive effect of Nori-peptides derived from red alga porphyra yezoensis in hypertensive patients

SAITO, M·2002·American Journal of Hypertension

Abstract

Nori-peptides have a potent angiotensin I converting enzyme (ACE) inhibitory activity. It has been fractionated from red alga porphyrayezoensis(Nori) by using iron-exchange and gel-filtration. Previous report showed that amino acid sequences of ACE inhibitory Nori-peptides were Ile-Tyr, Met-Lys-Tyr, Ala-Lys-Thy-Ser-Thyr, and Leu-Arg-Tyr, and 200mg/kg of Nori-peptides induced a significant blood pressure reduction in spontaneously hypertensive rats (Suetuna K. J Mar Biotechnol 1998; 6:163–167). We examined the efficacy and safety of Nori-peptides in humans. The subjects enrolled in this study were 64 hypertensive patients (36 men and 28 women, 59.9±2.0 years) and 29 normotensive subjects (15 men and 14 women, 51.9±3.6 years). Nori-peptides 1.8g/day was administered and change of blood pressure was followed for 35 days. Nori-peptide induced a significant blood pressure reduction in hypertensive patients (157.9±14.4/95.1±11.1 to 142.3±16.0/86.8±10.2 mmHg, p<0.001), but did not showed a significant depressor effect in normotensive Subjects (121.1±10.5/80.2 to 118.0 ±15.0/76.6±9.4 mmHg). There was no significant changes in clinical laboratory findings included blood count, serum creatinine, electrolyte, liver function test or blood glucose. It can be concluded that Nori-peptides have a significant antihypertensive effect in hypertensive patients as well as spontaneously hypertensive rats.

Integrity signals

Registry

Crossref · 10.1016/s0895-7061(02)02839-x

Cites

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Cited by

Sorted by citations

Authors
SAITO, M.
Corresponding author
SAITO, M
Venue
American Journal of Hypertension
Published
2002-04
Volume
15
Issue
4
Pages
A210
ISSN
0895-7061 (ISSN-L)
OpenAlex
W2032139220
Cited by
22
References
0
Citations by year
2026: 5 · 2025: 1 · 2024: 3 · 2023: 1 · 2022: 1 · 2021: 2 · 2020: 3 · 2018: 1 · 2013: 1 · 2012: 2
FWCI
0.12
Type
journal article
Language
en
Open access
closed
Locations
American Journal of Hypertension (publishedVersion)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Hydrolysis and Bioactive Peptides
  • Life Sciences › Agricultural and Biological Sciences › Aquatic Science › Seaweed-derived Bioactive Compounds
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Blood Pressure and Hypertension Studies
Keywords
Porphyra yezoensis, red algae, antihypertensive effect, angiotensin-converting enzyme inhibition, blood pressure reduction, hypertensive patients, safety, amino acid sequence, dietary peptides

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review